(1r,1's,4R,4'R)-4-Ethoxy-4'-propyl-1,1'-bi(cyclohexane), 95.0%, 10g

Butanoic acid, 3-methyl-2-[[[(phenylmethoxy)carbonyl]amino]methyl]-, (2R)-, 96%, 100mg

Pyridine-2-carbaldehyde, 97.0%, 5g

Chloro-o-xylene (mixture of 3- and 4-isomers)>97.0%(GC)500g

(1H-PYRAZOLO[3,4-B]PYRIDIN-5-YL)BORONIC ACID, 95%, 1g

tert-Butyl 4-[(tetrahydro-2H-pyran-4-carbonyl)amino]piperidine-1-carboxylate, 95.0%, 1g

(3S)-3-(Propan-2-yl)pyrrolidine hydrochloride, 97%, 500mg

N-(9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide hydrate, 98+%, 25g

(2-Oxo-benzooxazol-3-yl)-acetic acid, 95.0%, 5g

4,4'-Di(1H-imidazol-1-yl)-1,1'-biphenyl, 97%, 5g

N-(5-Chloro-2-methoxyphenyl)-2-chloropropanamide, 98%, 2g

2-Chloro-5-methoxy-1H-benzo[d]imidazole, 95.0%, 1g

trans-4-Propylcyclohexanecarboxylic Acid>98.0%(T)(GC)25g